Literature DB >> 7431038

Macular cherry-red spot and myoclonus syndrome. Juvenile form of sialidosis.

A Federico, A Cecio, G A Battini, J C Michalski, G Strecker, G C Guazzi.   

Abstract

Macular cherry-red spot, myoclonus and progressive mental deterioration are described in a man of 16 years. Morphological examination of the liver, bone marrow and fibroblasts showed numerous vacuoles containing storage material in the cytoplasm of the cells. Twelve different oligosaccharides were isolated from urine and their structures were determined. All have N-acetylglucosamine in a reducing end and (2--3) and 2--6) neuraminic acid in the terminal position. This abnormal urinary oligosaccharide excretion is due to absence of (2--6) neuraminidase which was not detected in fibroblast culture. This case is discussed in relationship to other cases with macular cherry-red spot, myoclonus and oligosaccharide urinary excretion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7431038     DOI: 10.1016/0022-510x(80)90197-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria.

Authors:  K Harzer; M Cantz; A C Sewell; S S Dhareshwar; W Roggendorf; R W Heckl; O Schofer; R Thumler; J Peiffer; W Schlote
Journal:  Hum Genet       Date:  1986-11       Impact factor: 4.132

Review 2.  Drug Treatment of Progressive Myoclonic Epilepsy.

Authors:  Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

Review 3.  Urinary oligosaccharides in lysosomal and other metabolic disorders.

Authors:  A Federico; G Guazzi
Journal:  Ital J Neurol Sci       Date:  1982-03

4.  Pathological study on a severe sialidosis (alpha-neuraminidase deficiency).

Authors:  T Yamano; M Shimada; K Matsuzaki; Y Matsumoto; W Yoshihara; S Okada; K Inui; T Yutaka; H Yabuuchi
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.